{"legislative_session": "2026", "identifier": "HB 2081", "title": "Creates provisions relating to reporting requirements for entities that participate in the 340B drug pricing program", "from_organization": "~{\"classification\": \"lower\"}", "classification": ["bill"], "subject": ["DRUGS AND CONTROLLED SUBSTANCES", "PHARMACY"], "abstracts": [], "other_titles": [{"note": "official", "title": "HB 2081"}], "other_identifiers": [], "actions": [{"description": "Prefiled (H)", "date": "2025-12-01T06:00:00+00:00", "organization_id": "~{\"classification\": \"lower\"}", "classification": [], "related_entities": []}], "sponsorships": [{"name": "Ben Keathley", "classification": "primary", "entity_type": "person", "primary": true, "person_id": "~{\"name\": \"Ben Keathley\"}", "organization_id": null}], "related_bills": [], "versions": [{"note": "Introduced", "links": [{"url": "https://documents.house.mo.gov/billtracking/bills261/hlrbillspdf/4030H.01I.pdf", "media_type": "application/pdf"}], "date": "", "classification": ""}], "documents": [], "citations": [], "sources": [{"url": "https://www.house.mo.gov/BillContent.aspx?bill=HB2081&year=2026&code=R&style=new", "note": ""}, {"url": "https://house.mo.gov/billactions.aspx?bill=HB2081&year=2026&code=R", "note": ""}], "extras": {}, "jurisdiction": {"id": "ocd-jurisdiction/country:us/state:mo/government", "name": "Missouri", "classification": "state", "division_id": "ocd-division/country:us/state:mo"}, "scraped_at": "2025-12-22T09:17:12+00:00", "_id": "ffe283d4-df16-11f0-ac17-32b82c3e8228"}